GammaTile Therapy is a safe and effective Surgically Targeted Radiation Therapy (STaRT) for operable brain tumors that begins working immediately at the time of brain tumor removal.
Delays brain tumor recurrence, potentially extending survival
Integrates into the surgical flow with an approximately 5-minute placement for procedural ease and speed
Enables patients with brain tumors to receive radiation treatment while going about their daily lives
Facilitates favorable reimbursement (CMS craniotomy code ICD-10 MS-DRG 023)
GammaTile Therapy is indicated to deliver radiation therapy for patients with newly diagnosed malignant intracranial neoplasms and recurrent intracranial neoplasms.
For full safety information, refer to the GammaTile Instructions for Use.
Nakaji P, Youssef E, Dardis C, Smith K, Pinnaduwage D, Brachman D. Surgically targeted radiation therapy: a prospective trial in 79 recurrent, previously irradiated intracranial neoplasms. Poster presented at: 2019 AANS Annual Scientific Meeting; April 2019; San Diego, CA.